---
title: "Kandi Technologies Warned by Nasdaq Over Minimum Bid Price Deficiency"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285772396.md"
description: "Kandi Technologies (KNDI) received a Nasdaq notification for non-compliance with the minimum bid price rule after its shares closed below $1.00 from March 23 to May 4, 2026. The company has until November 2, 2026, to restore compliance or may transfer to the Nasdaq Capital Market. Investors face delisting risk if shares trade at or below $0.10 for ten consecutive sessions. Spark's AI Analyst rates KNDI as Neutral, citing weak financial performance but a supportive balance sheet. Kandi Technologies focuses on intelligent vehicles and robotics, with a current market cap of $68.39M."
datetime: "2026-05-08T20:28:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285772396.md)
  - [en](https://longbridge.com/en/news/285772396.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285772396.md)
---

# Kandi Technologies Warned by Nasdaq Over Minimum Bid Price Deficiency

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Kandi Technologies ( (KNDI) ) just unveiled an update.

Kandi Technologies disclosed that it received a Nasdaq notification on May 5, 2026, indicating non-compliance with the exchange’s minimum bid price rule after its shares closed below $1.00 from March 23 through May 4, 2026. The notice does not immediately affect the stock’s listing on the Nasdaq Global Select Market, and the company now has until November 2, 2026, to restore its bid price to at least $1.00 for ten consecutive business days.

If Kandi fails to regain compliance by the November deadline, it may seek a transfer to the Nasdaq Capital Market for an additional compliance period, subject to meeting other listing standards and potentially undertaking measures such as a reverse stock split. The company plans to monitor its share price during the initial compliance window, while investors face heightened delisting risk should the stock trade at or below $0.10 for ten consecutive sessions, which would trigger a staff delisting determination.

**Spark’s Take on KNDI Stock**

According to Spark, TipRanks’ AI Analyst, KNDI is a Neutral.

The score is held down primarily by weak financial performance (declining revenue and widening losses) and bearish technicals (price below key moving averages with negative MACD). These are partially offset by a supportive balance sheet (reduced debt) and a sharp 2025 cash-flow rebound, though cash-flow durability remains uncertain; valuation is only middling with no dividend support.

To see Spark’s full report on KNDI stock, click here.

**More about Kandi Technologies**

Kandi Technologies Group, Inc. is a China-based, Nasdaq-listed technology company positioning itself as a global innovator in intelligent equipment and a technology-driven platform. Its strategy centers on all-domain intelligent vehicles, supported by battery-swapping equipment and intelligent robotics as key growth engines, leveraging advanced manufacturing and a global supply chain to broaden real-world technology applications.

**Average Trading Volume:** 271,262

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $68.39M

For a thorough assessment of KNDI stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [KNDI.US](https://longbridge.com/en/quote/KNDI.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [NIO Q1 Earnings Date Set for May 21 — Is This EV Stock Ready for a Breakout?](https://longbridge.com/en/news/286870895.md)
- [Polymarket debuts prediction markets tied to private companies](https://longbridge.com/en/news/286923554.md)
- [03:00 ETGreenberg Traurig's Capital Markets Practice Recognized Across Five Winning Deals of the Year at Islamic Finance News Awards 2025](https://longbridge.com/en/news/287020144.md)
- [Here's How Much $100 Invested In Copart 10 Years Ago Would Be Worth Today](https://longbridge.com/en/news/287117050.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)